Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

Source:http://linkedlifedata.com/resource/pubmed/id/11454878

J. Clin. Oncol. 2001 Jul 15 19 14 3312-22

Download in:

View as

Triples

General Info

PMID
11454878